University Medical Center Groningen
Clinical trials sponsored by University Medical Center Groningen, explained in plain language.
-
Immunotherapy before surgery shows promise for aggressive uterine cancer
Disease control OngoingThis study tests whether giving the immunotherapy drug pembrolizumab before standard hysterectomy can shrink tumors in people with a specific type of uterine cancer (MMRd). Twelve participants will receive 9 cycles of pembrolizumab, then have surgery as planned. The goal is to se…
Phase: PHASE2 • Sponsor: University Medical Center Groningen • Aim: Disease control
Last updated May 26, 2026 05:09 UTC
-
New hope for kidney patients: drug may slow damage without standard meds
Disease control ENROLLING_BY_INVITATIONThis study tests if the drug finerenone can reduce protein leakage in urine (a sign of kidney damage) better than a placebo. It involves 180 adults with chronic kidney disease who are not taking certain common blood pressure medicines. The goal is to see if finerenone can help co…
Phase: PHASE3 • Sponsor: University Medical Center Groningen • Aim: Disease control
Last updated May 26, 2026 05:06 UTC
-
Could a common diabetes drug save lives in severe kidney disease?
Disease control ENROLLING_BY_INVITATIONThis study tests whether dapagliflozin, a drug originally for diabetes, can reduce the risk of death, kidney failure, or heart failure hospitalization in people with severe chronic kidney disease, including those on dialysis or with a kidney transplant. About 1,750 adults with ad…
Phase: PHASE3 • Sponsor: University Medical Center Groningen • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
New combo therapy aims to boost survival in aggressive rectal cancer
Disease control OngoingThis study compares two treatment plans for people with high-risk rectal cancer. The standard plan is long-course chemoradiation followed by surgery and optional chemo. The experimental plan starts with short-course radiation (5 days), then several months of chemo, followed by su…
Phase: PHASE3 • Sponsor: University Medical Center Groningen • Aim: Disease control
Last updated May 20, 2026 11:53 UTC
-
New scan may predict who benefits from CAR T-Cell therapy for lymphoma
Knowledge-focused OngoingThis study tests a new type of PET scan that looks for a protein called PD-L1 in people with large B-cell lymphoma before they receive CAR T-cell therapy. The goal is to see if the scan can help predict who will respond to treatment and tell the difference between active lymphoma…
Phase: PHASE2 • Sponsor: University Medical Center Groningen • Aim: Knowledge-focused
Last updated May 26, 2026 05:03 UTC
-
Testicular cancer survivors: new study seeks to uncover hidden heart risks
Knowledge-focused OngoingThis study looks at why testicular cancer survivors may have a higher risk of heart disease. Researchers will follow nearly 1,000 men who had testicular cancer between 1976 and 2007, focusing on how their cancer treatment (like chemotherapy) might affect heart health over time. T…
Sponsor: University Medical Center Groningen • Aim: Knowledge-focused
Last updated May 26, 2026 04:38 UTC
-
Stem cells may reveal why chemo harms some hearts
Knowledge-focused OngoingThis study looks at why certain cancer drugs cause serious heart or lung damage in some patients but not others. Researchers will take skin or blood cells from 20 people who had extreme side effects and turn them into heart cells in a lab to study the reaction. The goal is to fin…
Sponsor: University Medical Center Groningen • Aim: Knowledge-focused
Last updated May 26, 2026 04:34 UTC
-
Brain scans reveal why some shed pounds after surgery while others Don't
Knowledge-focused OngoingThis study looks at why some people lose more weight than others after bariatric surgery. Researchers will use brain scans (PET) to measure changes in the brain's reward system, specifically dopamine receptors, in 30 adults who had surgery 2-3 years ago. The goal is to understand…
Phase: NA • Sponsor: University Medical Center Groningen • Aim: Knowledge-focused
Last updated May 18, 2026 12:00 UTC
-
Scientists peek inside the gut to understand how immunotherapy works
Knowledge-focused OngoingThis study looks at how the immune system in the gut changes when people with cancer receive immunotherapy. Researchers will take small tissue samples from the gut and blood samples before and during treatment. The goal is to learn more about the body's response, not to test a ne…
Sponsor: University Medical Center Groningen • Aim: Knowledge-focused
Last updated May 07, 2026 18:41 UTC